The IKK/NF-κB pathway
Uwe Senftleben, Michael Karin · Critical Care Medicine · 2002
From the Laboratory of Gene Regulation and Signal Transduction, the Department of Pharmacology, University of California, San Diego, La Jolla, CA. Although there are still years of intensive work ahead of us, the IKK/NF-κB pathway is a promising and important star on the intensive care horizon. Present address of Dr. Senftleben: Clinic of Anesthesiology, University of Ulm, Steinhövelstr. 9, 89075 Ulm, Germany. Address requests for reprints to: Michael Karin, PhD, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0636. E-mail: [email protected]
Cited by 244 works. doi:10.1097/00003246-200201001-00003
Authors
References
- Function and Activation of NF-Kappa B in the Immune System
- Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
- THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
- IκB: a Specific Inhibitor of the NF-κB Transcription Factor
- Oxygen-Derived Free Radicals in Postischemic Tissue Injury
- Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
- The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
- A cytokine-responsive IκB kinase that activates the transcription factor NF-κB